{"id":8353,"date":"2026-03-16T02:24:47","date_gmt":"2026-03-16T02:24:47","guid":{"rendered":"https:\/\/new.iho-us.org\/%d8%a7%d8%b1%d8%aa%d9%81%d8%a7%d8%b9-%d8%b6%d8%ba%d8%b7-%d8%a7%d9%84%d8%af%d9%85-%d9%84%d8%af%d9%89-%d9%83%d8%a8%d8%a7%d8%b1-%d8%a7%d9%84%d8%b3%d9%86-%d8%aa%d8%ad%d8%af%d9%8a%d8%a7%d8%aa-%d9%88%d8%a7\/"},"modified":"2026-04-16T19:47:48","modified_gmt":"2026-04-16T19:47:48","slug":"hypertension-in-older-adults-challenges-and-global-strategies-for-diagnosis-and-management","status":"publish","type":"post","link":"https:\/\/new.iho-us.org\/en\/hypertension-in-older-adults-challenges-and-global-strategies-for-diagnosis-and-management\/","title":{"rendered":"Hypertension in Older Adults: Challenges and Global Strategies for Diagnosis and Management"},"content":{"rendered":"<p data-start=\"74\" data-end=\"168\"><strong data-start=\"74\" data-end=\"168\">Hypertension in Older Adults: Challenges and Global Strategies for Diagnosis and Treatment<\/strong><\/p>\n<p data-start=\"170\" data-end=\"632\">Hypertension is one of the most common chronic diseases among older adults worldwide. It is the leading risk factor for cardiovascular diseases, stroke, and renal failure, which together represent the primary cause of mortality and disability in this age group. With the rapid demographic shift toward aging societies, hypertension has become an urgent public health issue that requires a coordinated international response.<\/p>\n<h3 data-section-id=\"vww99g\" data-start=\"634\" data-end=\"700\">Characteristics and Challenges of Hypertension in Older Adults<\/h3>\n<p data-start=\"702\" data-end=\"893\"><strong data-start=\"702\" data-end=\"733\">Epidemiological prevalence:<\/strong> The prevalence of hypertension exceeds 60% among people aged 60 years and older in many countries, and rises to more than 80% among those over 80 years of age.<\/p>\n<p data-start=\"895\" data-end=\"1140\"><strong data-start=\"895\" data-end=\"915\">Unique patterns:<\/strong> The pattern of <strong data-start=\"931\" data-end=\"965\">isolated systolic hypertension<\/strong> predominates due to the loss of elasticity in the large arteries with advancing age, where systolic blood pressure rises while diastolic blood pressure remains normal or low.<\/p>\n<p data-start=\"1142\" data-end=\"1221\"><strong data-start=\"1142\" data-end=\"1166\">Clinical complexity:<\/strong> Hypertension in older adults is often associated with:<\/p>\n<ul data-start=\"1223\" data-end=\"1568\">\n<li data-section-id=\"1f241tm\" data-start=\"1223\" data-end=\"1311\"><strong data-start=\"1225\" data-end=\"1244\">Multimorbidity:<\/strong> such as diabetes, dyslipidemia, kidney failure, and osteoporosis<\/li>\n<li data-section-id=\"45icvq\" data-start=\"1312\" data-end=\"1361\"><strong data-start=\"1314\" data-end=\"1335\">Frailty syndrome:<\/strong> and loss of muscle mass<\/li>\n<li data-section-id=\"lvisgg\" data-start=\"1362\" data-end=\"1461\"><strong data-start=\"1364\" data-end=\"1381\">Polypharmacy:<\/strong> which increases the risk of drug interactions and poor adherence to treatment<\/li>\n<li data-section-id=\"n53mft\" data-start=\"1462\" data-end=\"1568\"><strong data-start=\"1464\" data-end=\"1490\">Physiological changes:<\/strong> such as decreased glomerular filtration rate, which affects drug metabolism<\/li>\n<\/ul>\n<p data-start=\"1570\" data-end=\"1731\"><strong data-start=\"1570\" data-end=\"1596\">Diagnostic challenges:<\/strong> There is a higher risk of <strong data-start=\"1623\" data-end=\"1650\">white coat hypertension<\/strong> and difficulty in obtaining accurate measurements because of arterial stiffness.<\/p>\n<h3 data-section-id=\"11knwek\" data-start=\"1733\" data-end=\"1767\">Treatment Goals and Management<\/h3>\n<p data-start=\"1769\" data-end=\"1931\">Treatment recommendations differ slightly among international organizations, but there is broad agreement on the importance of balancing effectiveness and safety.<\/p>\n<p data-start=\"1933\" data-end=\"2417\"><strong data-start=\"1933\" data-end=\"1960\">Blood pressure targets:<\/strong> Most guidelines, such as those of the American College of Cardiology\/American Heart Association (ACC\/AHA) and the European Society of Cardiology (ESC), recommend achieving a target of less than <strong data-start=\"2155\" data-end=\"2170\">130\/80 mmHg<\/strong> for older adults in good overall health, with flexibility to adopt a less strict target, such as <strong data-start=\"2268\" data-end=\"2289\">below 140\/90 mmHg<\/strong>, for frail individuals or those over 80 years old, in order to avoid the harmful effects of excessive blood pressure reduction.<\/p>\n<p data-start=\"2419\" data-end=\"2442\"><strong data-start=\"2419\" data-end=\"2442\">Treatment strategy:<\/strong><\/p>\n<ul data-start=\"2444\" data-end=\"3135\">\n<li data-section-id=\"107fh1q\" data-start=\"2444\" data-end=\"2633\"><strong data-start=\"2446\" data-end=\"2484\">Non-pharmacological modifications:<\/strong> reducing sodium intake, adopting the DASH diet, engaging in age-appropriate physical activity, weight management, and limiting alcohol consumption<\/li>\n<li data-section-id=\"1k6lkme\" data-start=\"2634\" data-end=\"2973\"><strong data-start=\"2636\" data-end=\"2653\">Drug therapy:<\/strong> usually begins with low doses and gradual adjustment (<strong data-start=\"2708\" data-end=\"2732\">\u201cstart low, go slow\u201d<\/strong>). Preferred first-line options include <strong data-start=\"2772\" data-end=\"2824\">angiotensin-converting enzyme inhibitors (ACEIs)<\/strong>, <strong data-start=\"2826\" data-end=\"2866\">angiotensin receptor blockers (ARBs)<\/strong>, <strong data-start=\"2868\" data-end=\"2903\">calcium channel blockers (CCBs)<\/strong>, or <strong data-start=\"2908\" data-end=\"2930\">thiazide diuretics<\/strong>. Combination therapy is often necessary.<\/li>\n<li data-section-id=\"15uuk1d\" data-start=\"2974\" data-end=\"3135\"><strong data-start=\"2976\" data-end=\"3005\">Management of complexity:<\/strong> coordinating care to manage all chronic conditions together, and reviewing medications regularly to simplify treatment regimens<\/li>\n<\/ul>\n<h3 data-section-id=\"1pxis0u\" data-start=\"3137\" data-end=\"3203\">Recommendations of the International Health Organization (IHO)<\/h3>\n<ul data-start=\"3205\" data-end=\"4466\">\n<li data-section-id=\"jvtoac\" data-start=\"3205\" data-end=\"3414\"><strong data-start=\"3207\" data-end=\"3243\">Strengthening national policies:<\/strong> Supporting countries in developing and implementing simple, context-specific national guidelines for managing hypertension in older adults, with a focus on primary care<\/li>\n<li data-section-id=\"n6c0jl\" data-start=\"3415\" data-end=\"3596\"><strong data-start=\"3417\" data-end=\"3453\">Adopting innovative care models:<\/strong> Encouraging models such as multidisciplinary care teams, community pharmacy services, and supported self-care using technology (<strong data-start=\"3582\" data-end=\"3593\">eHealth<\/strong>)<\/li>\n<li data-section-id=\"1ae6dpv\" data-start=\"3597\" data-end=\"3825\"><strong data-start=\"3599\" data-end=\"3634\">Investing in capacity building:<\/strong> Training healthcare providers in accurate diagnosis, including blood pressure measurement outside the clinic, selecting appropriate treatment, and applying the principles of geriatric care<\/li>\n<li data-section-id=\"18a6fup\" data-start=\"3826\" data-end=\"3997\"><strong data-start=\"3828\" data-end=\"3871\">Ensuring access to essential medicines:<\/strong> Working to make low-cost and effective antihypertensive drug regimens available and affordable in all healthcare facilities<\/li>\n<li data-section-id=\"d2fki0\" data-start=\"3998\" data-end=\"4246\"><strong data-start=\"4000\" data-end=\"4022\">Research and data:<\/strong> Supporting research to close the knowledge gap regarding hypertension management in special groups of older adults, such as the frail and the very old, and strengthening surveillance systems to monitor trends and outcomes<\/li>\n<li data-section-id=\"11dede1\" data-start=\"4247\" data-end=\"4466\"><strong data-start=\"4249\" data-end=\"4273\">Awareness campaigns:<\/strong> Designing awareness campaigns targeting older adults and their families about the importance of regular blood pressure monitoring, adherence to treatment, and healthy lifestyle modifications<\/li>\n<\/ul>\n<p data-start=\"4468\" data-end=\"5063\">Effective control of hypertension in older adults is not merely a medical intervention; it is an investment in public health and an essential condition for achieving <strong data-start=\"4634\" data-end=\"4654\">\u201chealthy aging,\u201d<\/strong> as advocated by the World Health Organization. This requires a comprehensive, person-centered approach that addresses age-related complexities and balances the benefits of lowering blood pressure against the risks of intensive treatment. Global leadership and coordination among countries are essential to confront this challenge and improve the quality of life for millions of older adults around the world.<\/p>\n<p data-start=\"5065\" data-end=\"5132\"><strong data-start=\"5065\" data-end=\"5081\">Prepared by:<\/strong><br data-start=\"5081\" data-end=\"5084\" \/><strong data-start=\"5084\" data-end=\"5105\">Dr. Ibrahim Khudr<\/strong><br data-start=\"5105\" data-end=\"5108\" \/><strong data-start=\"5108\" data-end=\"5132\">Community Pharmacist<\/strong><\/p>\n<h3 data-section-id=\"1t86an2\" data-start=\"5134\" data-end=\"5148\">References<\/h3>\n<p data-start=\"5150\" data-end=\"5411\">Williams, B., et al. (2018). <em data-start=\"5179\" data-end=\"5249\">2018 ESC\/ESH Guidelines for the management of arterial hypertension.<\/em> European Heart Journal, 39(33), 3021\u20133104.<br data-start=\"5292\" data-end=\"5295\" \/>The main European reference providing detailed guidelines, including a special section on treatment in older adults.<\/p>\n<p data-start=\"5413\" data-end=\"5663\">Unger, T., et al. (2020). <em data-start=\"5439\" data-end=\"5524\">2020 International Society of Hypertension Global Hypertension Practice Guidelines.<\/em> Hypertension, 75(6), 1334\u20131357.<br data-start=\"5556\" data-end=\"5559\" \/>Provides practical global guidelines while taking into account different levels of healthcare resources.<\/p>\n<p data-start=\"5665\" data-end=\"6009\">World Health Organization. (2021). <em data-start=\"5700\" data-end=\"5824\">HEARTS technical package for cardiovascular disease management in primary health care: evidence-based treatment protocols.<\/em> Geneva: World Health Organization.<br data-start=\"5859\" data-end=\"5862\" \/>Outlines a practical technical package to support countries in managing cardiovascular diseases, including hypertension, at the primary care level.<\/p>\n<p data-start=\"6011\" data-end=\"6243\">Benetos, A., et al. (2019). <em data-start=\"6039\" data-end=\"6099\">Hypertension management in older and frail older patients.<\/em> Circulation Research, 124(7), 1045\u20131060.<br data-start=\"6140\" data-end=\"6143\" \/>A comprehensive review focusing on the complexities of hypertension treatment in frail older adults.<\/p>\n<p data-start=\"6245\" data-end=\"6586\">American College of Cardiology\/American Heart Association. (2017). <em data-start=\"6312\" data-end=\"6469\">2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.<\/em> Hypertension, 71(6), e13\u2013e115.<br data-start=\"6500\" data-end=\"6503\" \/>The American guideline that stimulated debate regarding stricter treatment targets.<\/p>\n<p data-start=\"6588\" data-end=\"6744\">Mancia, G., &amp; Grassi, G. (2019). <em data-start=\"6621\" data-end=\"6683\">Management of hypertension in the elderly and frail elderly.<\/em> High Blood Pressure &amp; Cardiovascular Prevention, 26(1), 1\u20137.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hypertension in Older Adults: Challenges and Global Strategies for Diagnosis and Treatment Hypertension is one of the most common chronic diseases among older adults worldwide. It is the leading risk factor for cardiovascular diseases, stroke, and renal failure, which together&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-8353","post","type-post","status-publish","format-standard","hentry","category-articles"],"_links":{"self":[{"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/posts\/8353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/comments?post=8353"}],"version-history":[{"count":3,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/posts\/8353\/revisions"}],"predecessor-version":[{"id":8356,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/posts\/8353\/revisions\/8356"}],"wp:attachment":[{"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/media?parent=8353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/categories?post=8353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.iho-us.org\/en\/wp-json\/wp\/v2\/tags?post=8353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}